Latest immunotherapy News

Immutep appoints research institute to conduct first-in-human study of IMP761
World-class cancer research centre announced for QIMR Berghofer
Princess Alexandra Hospital home to world first cancer trial
What Are Types Of Cancer Treatments?
Ludwig Cancer Research Scientists to Present at AACR Annual Meeting
The Swedish Childhood Cancer Fund finances 8 research positions at KI
New Hope In Immunotherapy Against Cancer
Breakthroughs In Cancer Care With Professor Robyn Ward
Preparing For Allergic Reaction
Honey is said to help with hay fever symptoms – here’s what the research says about this claim
Cancer often requires more than one treatment − an oncologist explains why some patients like Kate Middleton receive both chemotherapy and surgery
Kate Middleton is having ‘preventive chemotherapy’ for cancer. What does this mean?
What Causes Breast Cancer?
Queensland Research Team Targets Ovarian Cancer Vaccine
Consortium identifies 5 grand challenges in biomedical engineering
Study Shines New Light On Immune Response
What you need to know about new treatments for children with peanut allergies
Mater People Ride To Raise Funds For Cancer 14 March
Trial Finds New Bladder Cancer Treatment Safe 13 March
Immune cells can adapt to invading pathogens, deciding whether to fight now or prepare for the next battle
Early Start To Spring Allergies
Studying Unusual Immunodeficiency
Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative breast cancer
Genetic signature may predict lung cancer response to immunotherapy
Future Of Cancer Research With Professor Alex Swarbrick
MinterEllison advises Aravax on US$68 million raising for peanut allergy therapy
Funding turbocharges search for children’s brain cancer cure
Trial finds new bladder cancer treatment safe
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Why Warren and Donna are Charging this March
Trial increases survival rates for mesothelioma patients
Capping off a year of generosity
Healthy investment in better patient outcomes
Improving survival rates for deadly lung diseases
King Charles is having cancer treatment. What can he, and others with cancer, expect?
Novel treatment for brain cancer in children
Immune networks in tumors prime responses to a personalized immunotherapy
New drug halts growth of aggressive breast cancer
Sowing seeds for better cancer outcomes
Improving cancer outcomes by helping regional patients join clinical trials
Arovella licences novel CARiNKT cell armouring technology
Pioneering melanoma researchers named 2024 Australian of the Year
Immunologist Lydia Lynch appointed member of Ludwig Princeton
Congratulations to NSW professor duo with top 2024 Australians of the Year honour
How a timekeeping gene affects tumor growth depends entirely on context
Investing in ground breaking peanut allergy therapy
Made In Victoria: Groundbreaking Peanut Allergy Therapy
From melanoma survivor to skin cancer advocate – Nicole’s story